Published in Macromol Biosci on September 09, 2009
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A (2011) 1.66
Adaptable hydrogel networks with reversible linkages for tissue engineering. Adv Mater (2015) 0.85
Preparation, modification, and characterization of alginate hydrogel with nano-/microfibers: a new perspective for tissue engineering. Biomed Res Int (2013) 0.76
Injectable scaffolds: Preparation and application in dental and craniofacial regeneration. Mater Sci Eng R Rep (2017) 0.75
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials (2003) 7.15
Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater (2010) 5.36
Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med (2006) 5.10
Engineering tumors with 3D scaffolds. Nat Methods (2007) 3.96
Highly stretchable and tough hydrogels. Nature (2012) 3.34
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Alginate hydrogels as biomaterials. Macromol Biosci (2006) 2.94
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Inspiration and application in the evolution of biomaterials. Nature (2009) 2.23
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol (2012) 2.17
FRET measurements of cell-traction forces and nano-scale clustering of adhesion ligands varied by substrate stiffness. Proc Natl Acad Sci U S A (2005) 2.07
Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A (2009) 2.07
Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone (2004) 2.05
Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res (2002) 2.04
Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res (2006) 2.03
Infection-mimicking materials to program dendritic cells in situ. Nat Mater (2009) 2.00
Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study. J Am Acad Dermatol (2013) 1.97
Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A (2008) 1.96
Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials (2005) 1.89
Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials (2006) 1.88
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A (2009) 1.83
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater (2005) 1.83
Label-free biomarker detection from whole blood. Nat Nanotechnol (2009) 1.80
Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J (2005) 1.79
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res (2007) 1.77
Engineering growing tissues. Proc Natl Acad Sci U S A (2002) 1.76
Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation (2007) 1.75
Polymeric growth factor delivery strategies for tissue engineering. Pharm Res (2003) 1.74
Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials (2005) 1.74
New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol (2008) 1.69
In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med (2009) 1.65
Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res (2007) 1.64
Controlled growth factor delivery for tissue engineering. Adv Mater (2009) 1.63
VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res (2006) 1.63
Engineering vascular networks in porous polymer matrices. J Biomed Mater Res (2002) 1.60
Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells. Biochem Biophys Res Commun (2011) 1.58
Active scaffolds for on-demand drug and cell delivery. Proc Natl Acad Sci U S A (2010) 1.58
The tensile properties of alginate hydrogels. Biomaterials (2004) 1.57
Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech (2003) 1.56
Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials (2011) 1.51
Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc (2002) 1.51
Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A (2006) 1.46
Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules (2004) 1.44
Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res (2005) 1.43
Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg (2005) 1.43
An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials (2010) 1.42
Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng (2007) 1.40
Enhancement of human peripheral blood mononuclear cell transplantation-mediated bone formation. Cell Transplant (2011) 1.40
Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng (2003) 1.39
Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials (2003) 1.39
Pitfalls of using dermatoscopy in defining surgical margins of basal cell carcinoma. Dermatol Surg (2011) 1.39
Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun (2008) 1.37
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc Natl Acad Sci U S A (2013) 1.35
Integrated approach to designing growth factor delivery systems. FASEB J (2007) 1.35
Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials (2005) 1.34
Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc Natl Acad Sci U S A (2006) 1.34
Differentiation stage alters matrix control of stem cells. J Biomed Mater Res A (2008) 1.33
Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng (2002) 1.33
Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials (2005) 1.33
Can tissue engineering concepts advance tumor biology research? Trends Biotechnol (2010) 1.32
Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials (2009) 1.32
Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials (2007) 1.31
In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials (2007) 1.29
Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci U S A (2012) 1.28
Cutaneous metaplastic synovial cyst of the cheek generated by repetitive minor trauma. Ann Dermatol (2011) 1.27
Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces. Arch Biochem Biophys (2004) 1.26
Mechanical strain regulates endothelial cell patterning in vitro. Tissue Eng (2007) 1.26
Macroscale delivery systems for molecular and cellular payloads. Nat Mater (2013) 1.25
Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A (2006) 1.23
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Polymers for pro- and anti-angiogenic therapy. Biomaterials (2007) 1.19
Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials (2005) 1.17
Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol (2003) 1.16
Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells (2005) 1.16
Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials (2007) 1.16
Prevalence of the major mental disorders among the Korean elderly. J Korean Med Sci (2010) 1.15
Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (2005) 1.15
Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells (2006) 1.15
Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res A (2003) 1.15
Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials (2013) 1.14
A bioinspired soft actuated material. Adv Mater (2013) 1.14
Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev (2006) 1.13
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng (2004) 1.10
Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res (2008) 1.10
Microenvironmental regulation of biomacromolecular therapies. Nat Rev Drug Discov (2007) 1.10
The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials (2011) 1.09
Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng Part A (2009) 1.09
Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng (2006) 1.09
N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release (2006) 1.09
Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone (2011) 1.09
Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. Nano Lett (2007) 1.09
Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. Nano Lett (2010) 1.08